RxDoctor Payments Data

Reshma Patel

Pediatric Rheumatology · Madera, CANPI 1639420540

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Amgen at 55.3% of the total. Reporting peaked in 2019 at $1,215 and has fallen 50.2% since, to $605 in 2024.

$3,337in general payments, 2019–2025

Across 132 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Novartis$290
  • Pfizer$230
  • GSK$151
  • Medexus Pharma, Inc.$133
  • E.r. Squibb & Sons, L.L.C.$126
  • plus $561 from 10 others

What the payments were for

  • Food & beverage$3,27998%
  • Education$572%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,337 in reported general payments places this provider in the 75th percentile of 39 pediatric rheumatology providers in California.

See all pediatric rheumatology providers in California

Other pediatric rheumatology in Madera

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →